Home / Companies / Novartis Gene Therapies Inc / Wages
Novartis Gene Therapies Inc H-1B wage rows
Compensation-first LCA rows for Novartis Gene Therapies Inc, including offered wage, annualized wage, worksite, SOC code, fiscal year, QA flags, and source record evidence. Showing 32 returned rows using keyset pagination.
Summary
This view lists 32 H-1B LCA wage observations.
Offered wages among the returned rows range from $63,856 to $169,542.
Employers in the returned rows include Novartis Gene Therapies, Inc..
LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Returned-page wage summary
| Scope | returned_page |
| Count | 32 |
| Annualized Min | 63,856 |
| Annualized P25 | 79,747 |
| Annualized Median | 98,218 |
| Annualized P75 | 112,320 |
| Annualized P90 | 154,856 |
| Annualized Max | 169,542 |
| Outlier Count | 0 |
| Role | Employer | SOC | Fiscal year | Worksite | Annualized offer | Spread | QA flags | Source |
|---|---|---|---|---|---|---|---|---|
| Manufacturing Quality Assurance Specialist I-200-25311-390184 | Novartis Gene Therapies, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2026 Q2 | Durham, NC, 27713 | $98,218 year | $13,271 | missing_offer_high | sr_dol_oflc_lca_2026_q2_row_177688 |
| Quality Control Specialist I-200-25269-338870 | Novartis Gene Therapies, Inc. | 19-2031.00 Chemists | FY2026 Q2 | Durham, NC, 27713 | $75,691 year | $0 | missing_offer_high | sr_dol_oflc_lca_2026_q2_row_202756 |
| Sr Engineer, Manufacturing Science &Tech I-200-25246-283053 | Novartis Gene Therapies, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2025 Q4 | Durham, NC, 27713 | $112,757 year | $8,362 | missing_offer_high | sr_dol_oflc_lca_2025_q4_row_026645 |
| Specialist, Quality Control I-200-25150-034310 | Novartis Gene Therapies, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2025 Q3 | Durham, NC, 27713 | $84,344 year | $0 | missing_offer_high | sr_dol_oflc_lca_2025_q3_row_065426 |
| Specialist, Quality Control IT I-200-25119-918670 | Novartis Gene Therapies, Inc. | 11-3051.01 Quality Control Systems Managers | FY2025 Q3 | Durham, NC, 27713 | $112,320 year | $0 | missing_offer_high | sr_dol_oflc_lca_2025_q3_row_155757 |
| Senior Specialist, Quality Assurance I-200-24284-400018 | Novartis Gene Therapies, Inc. | 19-2031.00 Chemists | FY2025 Q1 | Durham, NC, 27713 | $92,206 year | $0 | missing_offer_high | sr_dol_oflc_lca_2025_q1_row_085114 |
| Manufacturing Quality Assurance Specialist I-200-23087-882871 | Novartis Gene Therapies, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2023 Q3 | Durham, NC, 27713 | $78,874 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q3_row_182143 |
| Manufacturing Quality Assurance Specialist I-200-23080-864648 | Novartis Gene Therapies, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2023 Q2 | Durham, NC, 27713 | $78,874 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q2_row_008089 |
| Engineer, Manufacturing Science and Technology I-200-23069-838601 | Novartis Gene Therapies, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2023 Q2 | Durham, NC, 27713 | $99,466 year | $5,034 | missing_offer_high | sr_dol_oflc_lca_2023_q2_row_025736 |
| Senior Analyst, Quality Control I-200-23067-831629 | Novartis Gene Therapies, Inc. | 19-2031.00 Chemists | FY2023 Q2 | Durham, NC, 27713 | $73,050 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q2_row_029587 |
| Senior Engineer, Manufacturing Science I-200-22273-505190 | Novartis Gene Therapies, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2023 Q1 | Libertyville, IL, 60048 | $115,482 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q1_row_081292 |
| Senior Engineer, Manufacturing Science I-200-22273-505190 | Novartis Gene Therapies, Inc. | 17-2031.00 Bioengineers and Biomedical Engineers | FY2023 Q2 | Libertyville, IL, 60048 | $115,482 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q2_row_224707 |
| Specialist, Quality Control I-200-22272-502271 | Novartis Gene Therapies, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2023 Q1 | Durham, NC, 27713 | $108,950 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q1_row_083380 |
| Specialist, Quality Control I-200-22272-502271 | Novartis Gene Therapies, Inc. | 19-1021.00 Biochemists and Biophysicists | FY2023 Q2 | Durham, NC, 27713 | $108,950 year | $0 | missing_offer_high | sr_dol_oflc_lca_2023_q2_row_225540 |
| Senior Engineer, Manufacturing Science and Technology I-200-22125-138816 | Novartis Gene Therapies, Inc. | 17-2112.00 Industrial Engineers | FY2022 Q3 | Libertyville, IL, 60048 | $106,642 year | $0 | missing_offer_high | sr_dol_oflc_lca_2022_q3_row_098921 |
| Senior Project Manager, Manufacturing Science and Technology I-200-22112-097122 | Novartis Gene Therapies, Inc. | 13-1081.00 Logisticians | FY2022 Q3 | Durham, NC, 27713 | $100,838 year | $0 | missing_offer_high | sr_dol_oflc_lca_2022_q3_row_067609 |
| Quality Control Microbiology Supervisor I-200-22104-071346 | Novartis Gene Therapies, Inc. | 11-3051.01 Quality Control Systems Managers | FY2022 Q3 | Durham, NC, 27713 | $154,856 year | $0 | missing_offer_high | sr_dol_oflc_lca_2022_q3_row_046631 |
| Specialist, Quality Assurance - Quality Control I-200-22075-983603 | Novartis Gene Therapies, Inc. | 19-2031.00 Chemists | FY2022 Q2 | Durham, NC, 27713 | $79,414 year | $0 | missing_offer_high | sr_dol_oflc_lca_2022_q2_row_132454 |
| Bio Process Engineer II I-200-21362-789238 | Novartis Gene Therapies, Inc. | 17-2041.00 Chemical Engineers | FY2022 Q2 | Libertyville, IL, 60048 | $89,045 year | $0 | missing_offer_high | sr_dol_oflc_lca_2022_q2_row_003823 |
| Director, Global Real-World Evidence I-200-21294-658773 | Novartis Gene Therapies, Inc. | 15-2031.00 Operations Research Analysts | FY2022 Q1 | Ridgewood, NJ, 7450 | $141,378 year | $0 | missing_offer_high | sr_dol_oflc_lca_2022_q1_row_037800 |
| Business Systems Analyst I-200-21106-231938 | Novartis Gene Therapies, Inc. | 15-2031.00 Operations Research Analysts | FY2021 Q3 | Deerfield, IL, 60015 | $79,747 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q3_row_257735 |
| Process Science Engineer III I-200-21089-184677 | Novartis Gene Therapies, Inc. | 17-2112.00 Industrial Engineers | FY2021 Q3 | San Diego, CA, 92121 | $83,741 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q3_row_221434 |
| Senior Project Manager, Manufacturing Science and Technology I-200-21083-170718 | Novartis Gene Therapies, Inc. | 13-1081.00 Logisticians | FY2021 Q2 | Durham, NC, 27713 | $103,646 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q2_row_000041 |
| Senior Project Manager, Manufacturing Science and Technology I-200-21083-170718 | Novartis Gene Therapies, Inc. | 13-1081.00 Logisticians | FY2021 Q3 | Durham, NC, 27713 | $103,646 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q3_row_209503 |
| Manufacturing Quality Associate I-200-21060-110457 | Novartis Gene Therapies, Inc. | 13-1041.07 Regulatory Affairs Specialists | FY2021 Q2 | Libertyville, IL, 60048 | $63,856 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q2_row_046726 |
| Manufacturing Quality Associate I-200-21060-110457 | Novartis Gene Therapies, Inc. | 13-1041.07 Regulatory Affairs Specialists | FY2021 Q3 | Libertyville, IL, 60048 | $63,856 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q3_row_163522 |
| Associate Director, Regions Global Regulatory Affairs I-200-20345-949455 | Novartis Gene Therapies, Inc. | 11-9199 Managers, All Other | FY2021 Q1 | Bannockburn, IL, 60015 | $169,542 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q1_row_057262 |
| Business Systems Analyst 2 I-200-20346-952027 | Novartis Gene Therapies, Inc. | 15-1121 Computer Systems Analysts | FY2021 Q1 | North Royalton, OH, 44133 | $96,054 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q1_row_058627 |
| Associate Director, Regions Global Regulatory Affairs I-200-20345-949455 | Novartis Gene Therapies, Inc. | 11-9199.00 Managers, All Other | FY2021 Q3 | Bannockburn, IL, 60015 | $169,542 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q3_row_061625 |
| Business Systems Analyst 2 I-200-20346-952027 | Novartis Gene Therapies, Inc. | 15-1121.00 Computer Systems Analysts | FY2021 Q3 | North Royalton, OH, 44133 | $96,054 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q3_row_061938 |
| Associate Director, Regions Global Regulatory Affairs I-200-20345-949455 | Novartis Gene Therapies, Inc. | 11-9199.00 Managers, All Other | FY2021 Q2 | Bannockburn, IL, 60015 | $169,542 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q2_row_143518 |
| Business Systems Analyst 2 I-200-20346-952027 | Novartis Gene Therapies, Inc. | 15-1121.00 Computer Systems Analysts | FY2021 Q2 | North Royalton, OH, 44133 | $96,054 year | $0 | missing_offer_high | sr_dol_oflc_lca_2021_q2_row_145055 |
End of returned pageReset
Frequently asked questions
- What are the offered H-1B wages for Novartis Gene Therapies Inc H-1B wage rows?
- Offered wages among the returned Novartis Gene Therapies Inc H-1B wage rows rows range from $63,856 to $169,542 in DOL LCA filings. LCA filings are labor-condition applications certified by the U.S. Department of Labor, not active job postings or approved USCIS H-1B petitions.
Get this page with API
Rendered from the bluedoor H-1B Jobs API. Reproduce it:
GET https://api.bluedoor.sh/h1b-jobs/v1/wages?limit=50&company=novartis+gene+therapies+incJSON